CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas

被引:26
|
作者
Kim, Seong Ho [1 ,2 ]
Kim, Se Hyung [1 ,2 ]
Kim, Min-A [3 ]
Shin, Cheong-il [1 ,2 ]
Han, Joon Koo [1 ,2 ]
Choi, Byung Ihn [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehangno, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
基金
新加坡国家研究基金会;
关键词
Stomach; Neuroendocrine tumour; Adenocarcinoma; Metastasis; Computed tomography; ENDOCRINE TUMORS; CARCINOID-TUMORS; PATHOGENESIS; METASTASES; DISTENSION; CELL;
D O I
10.1007/s00330-015-3600-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To evaluate the differential CT features of gastric poorly-differentiated neuroendocrine tumours (PD-NETs) from well-differentiated NETs (WD-NETs) and gastric adenocarcinomas (ADCs) and to suggest differential features of hepatic metastases from gastric NETs and ADCs. Our study population was comprised of 36 patients with gastric NETs (18 WD-NETs, 18 PD-NETs) and 38 patients with gastric ADCs who served as our control group. Multiple CT features were assessed to identify significant differential CT findings of PD-NETs from WD-NETs and ADCs. In addition, CT features of hepatic metastases including the metastasis-to-liver ratio were analyzed to differentiate metastatic NETs from ADCs. The presence of metastatic lymph nodes was the sole differentiator of PD-NETs from WD-NETs (P = .001, odds ratio = 56.67), while the presence of intact overlying mucosa with mucosal tenting was the sole significant CT feature differentiating PD-NETs from ADCs (P = .047, odds ratio = 15.3) For hepatic metastases, metastases from NETs were more hyper-attenuated than those from ADCs. The presence of metastatic LNs and intact overlying mucosa with mucosal tenting are useful CT discriminators of PD-NETs from WD-NETs and ADCs, respectively. In addition, a higher metastasis-to-liver ratio may help differentiate hepatic metastases of gastric NETs from those of gastric ADCs with high accuracy. aEuro cent Presence of metastatic LNs is a useful differentiator of PD-NETs from WD-NETs. aEuro cent Intact overlying mucosa with mucosal tenting suggests PD-NETs more than gastric ADCs. aEuro cent Metastatic LNs are larger in size and greater in necrotic volume in PD-NETs. aEuro cent Hepatic metastases from gastric NETs are more hyper-attenuated than those from ADCs.
引用
收藏
页码:1946 / 1957
页数:12
相关论文
共 50 条
  • [31] Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
    Chen, Yue
    Liu, Fang
    Meng, Qingkai
    Ma, Siping
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [32] Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung
    Wolin, Edward M.
    CHEST, 2017, 151 (05) : 1141 - 1146
  • [33] Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours
    Ricci, Claudio
    Casadei, Riccardo
    Taffurelli, Giovanni
    Campana, Davide
    Ambrosini, Valentina
    Pagano, Nico
    Santini, Donatella
    De Giorgio, Roberto
    Ingaldi, Carlo
    Tomassetti, Paola
    Zani, Elia
    Minni, Francesco
    PANCREATOLOGY, 2016, 16 (03) : 403 - 410
  • [34] Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice
    Lamarca, Angela
    Clouston, Hamish
    Barriuso, Jorge
    McNamara, Mairead G.
    Frizziero, Melissa
    Mansoor, Was
    Hubner, Richard A.
    Manoharan, Prakash
    O'Dwyer, Sarah
    Valle, Juan W.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [35] Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
    Haug, Alexander
    Auernhammer, Christoph J.
    Waengler, Bjoern
    Tiling, Reinhold
    Schmidt, Gerwin
    Goeke, Burkhard
    Bartenstein, Peter
    Poepperl, Gabriele
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (05) : 765 - 770
  • [36] Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment
    Lamarca, Angela
    Cives, Mauro
    de Mestier, Louis
    Crona, Joakim
    Spada, Francesca
    Oberg, Kjell
    Pavel, Marianne
    Alonso-Gordoa, Teresa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (10) : 976 - 989
  • [37] Two well-differentiated pancreatic neuroendocrine tumor mouse models
    Wong, Chung
    Tang, Laura H.
    Davidson, Christian
    Vosburgh, Evan
    Chen, Wenjin
    Foran, David J.
    Notterman, Daniel A.
    Levine, Arnold J.
    Xu, Eugenia Y.
    CELL DEATH AND DIFFERENTIATION, 2020, 27 (01) : 269 - 283
  • [38] An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
    Korse, C. M.
    Taal, B. G.
    Bonfrer, J. M. G.
    Vincent, A.
    van Velthuysen, M. L.
    Baas, P.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2625 - 2630
  • [39] Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Cetinkaya, Raziye Boyar
    Vatn, Morten
    Aabakken, Lars
    Bergestuen, Deidi S.
    Thiis-Evensen, Espen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 734 - 741
  • [40] PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma
    Sangoi, Ankur R.
    Ohgami, Robert S.
    Pai, Rish K.
    Beck, Andrew H.
    McKenney, Jesse K.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2011, 24 (03) : 412 - 424